Cargando…
Aldehyde Dehydrogenase 2 Mediates Alcohol‐Induced Colorectal Cancer Immune Escape through Stabilizing PD‐L1 Expression
Despite the great success of immunotherapy in a small subset of cancer patients, most colorectal cancer (CRC) patients do not respond to programmed cell death receptor 1 (PD‐1) blockade immunotherapy. There is an urgent medical need to elucidate how cancer cells evade immune response and to develop...
Autores principales: | Zhang, Hong, Xia, Yuhui, Wang, Fang, Luo, Min, Yang, Ke, Liang, Shaobo, An, Sainan, Wu, Shaocong, Yang, Chuan, Chen, Da, Xu, Meng, Cai, Muyan, To, Kenneth K. W., Fu, Liwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132160/ https://www.ncbi.nlm.nih.gov/pubmed/34026438 http://dx.doi.org/10.1002/advs.202003404 |
Ejemplares similares
-
PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma
por: Luo, Min, et al.
Publicado: (2021) -
Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016) -
The Genetics of Alcohol Metabolism: Role of Alcohol Dehydrogenase and Aldehyde Dehydrogenase Variants
por: Edenberg, Howard J.
Publicado: (2007) -
Activity of Total Alcohol Dehydrogenase, Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase in the Serum of Patients with Alcoholic Fatty Liver Disease
por: Wolszczak-Biedrzycka, Blanka, et al.
Publicado: (2021) -
Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer
por: Luo, Min, et al.
Publicado: (2020)